Holen Sie sich die Stockscreener-App
85.12
0.44%
-0.38
Handel nachbörslich:
85.50
0.38
+0.45%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$85.50
Offen:
$86.025
24-Stunden-Volumen:
13.10M
Relative Volume:
1.93
Marktkapitalisierung:
$68.23B
Einnahmen:
$20.38B
Nettoeinkommen (Verlust:
$2.26B
KGV:
32.47
EPS:
2.6214
Netto-Cashflow:
$3.63B
1W Leistung:
-4.19%
1M Leistung:
-10.48%
6M Leistung:
+4.87%
1J Leistung:
-5.72%
1-Tages-Spanne:
$84.07
$86.14
1-Wochen-Bereich:
$84.07
$91.48
52-Wochen-Spanne:
$74.55
$99.33
Colgate Palmolive Co Stock (CL) Company Profile
Firmenname
Colgate Palmolive Co
Sektor
Telefon
(212) 310-2000
Adresse
300 PARK AVE, NEW YORK, NY
Compare CL vs PG, UL, KVUE, KMB
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CL
Colgate Palmolive Co
|
85.12 | 68.23B | 20.38B | 2.26B | 3.63B | 2.6214 |
PG
Procter Gamble Co
|
144.28 | 335.31B | 85.26B | 16.53B | 14.85B | 6.7488 |
UL
Unilever Plc Adr
|
61.48 | 134.33B | 56.67B | 6.96B | 7.39B | 3.1265 |
KVUE
Kenvue Inc
|
17.40 | 33.35B | 15.12B | 1.47B | 1.72B | 0.764 |
KMB
Kimberly Clark Corp
|
98.20 | 32.59B | 17.23B | 1.75B | 1.64B | 6.0654 |
Colgate Palmolive Co Stock (CL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-13 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2026-01-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-12-11 | Herabstufung | Argus | Buy → Hold |
| 2025-12-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-10-03 | Fortgesetzt | Piper Sandler | Neutral |
| 2024-10-28 | Herabstufung | Stifel | Buy → Hold |
| 2024-09-24 | Eingeleitet | Piper Sandler | Overweight |
| 2024-09-16 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-09-09 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2024-07-26 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-07-24 | Herabstufung | Jefferies | Buy → Hold |
| 2024-07-23 | Eingeleitet | TD Cowen | Buy |
| 2024-06-24 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2024-03-01 | Fortgesetzt | Goldman | Buy |
| 2024-01-29 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-12-15 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-11-13 | Eingeleitet | Jefferies | Buy |
| 2023-10-16 | Hochstufung | Stifel | Hold → Buy |
| 2023-09-22 | Eingeleitet | HSBC Securities | Buy |
| 2023-02-17 | Eingeleitet | Citigroup | Buy |
| 2023-01-30 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-11-22 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-10-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-08-01 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-05-03 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-04-08 | Eingeleitet | Raymond James | Mkt Perform |
| 2022-02-02 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2022-01-31 | Bestätigt | Citigroup | Neutral |
| 2022-01-31 | Bestätigt | Credit Suisse | Outperform |
| 2022-01-31 | Bestätigt | Deutsche Bank | Buy |
| 2022-01-31 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-01-31 | Bestätigt | Wells Fargo | Underweight |
| 2021-12-16 | Eingeleitet | Redburn | Neutral |
| 2021-10-05 | Fortgesetzt | BofA Securities | Neutral |
| 2021-09-20 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-06-24 | Eingeleitet | UBS | Buy |
| 2021-06-09 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-02-01 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2021-01-28 | Herabstufung | Stifel | Buy → Hold |
| 2021-01-26 | Hochstufung | Berenberg | Sell → Hold |
| 2021-01-20 | Eingeleitet | Bernstein | Underperform |
| 2021-01-04 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-12-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-07-22 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-03-27 | Hochstufung | Stifel | Hold → Buy |
| 2020-03-27 | Hochstufung | SunTrust | Hold → Buy |
| 2020-03-23 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-03-20 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-02-03 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2020-02-03 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-12-19 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-10-16 | Eingeleitet | Berenberg | Sell |
| 2019-04-29 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2019-03-07 | Eingeleitet | Credit Suisse | Underperform |
| 2019-02-11 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
| 2019-01-11 | Eingeleitet | Evercore ISI | Outperform |
| 2019-01-09 | Hochstufung | Goldman | Neutral → Buy |
| 2018-10-29 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2018-10-26 | Herabstufung | SunTrust | Buy → Hold |
| 2018-07-30 | Herabstufung | Macquarie | Outperform → Neutral |
| 2018-05-25 | Hochstufung | Argus | Hold → Buy |
| 2018-04-30 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
Alle ansehen
Colgate Palmolive Co Aktie (CL) Neueste Nachrichten
What Colgate-Palmolive (CL)'s Premium Optic White Pro Series Launch Means For Shareholders - simplywall.st
Colgate-Palmolive Company $CL is Sarasin & Partners LLP's 7th Largest Position - MarketBeat
Colgate-Palmolive Co stock gains momentum on NYSE as analysts upgrade ratings amid steady dividend h - AD HOC NEWS
A Look At Colgate-Palmolive (CL) Valuation After Dividend Hike And New Optic White Pro Series Launch - simplywall.st
Colgate-Palmolive Stock Hits Day Low Amid Price Pressure, Closing at $85.46 - Markets Mojo
AIA Group Ltd Takes $2.11 Million Position in Colgate-Palmolive Company $CL - MarketBeat
Wall Street Zen Upgrades Colgate-Palmolive (NYSE:CL) to Buy - MarketBeat
Does Colgate-Palmolive (CL) Justify Its Premium Valuation After Mixed Recent Share Performance - simplywall.st
Colgate-Palmolive Co stock faces pressure amid earnings beat and short-term decline on NYSE - AD HOC NEWS
Groupama Asset Managment Acquires 23,707 Shares of Colgate-Palmolive Company $CL - MarketBeat
100 million Filipino children to receive oral health kits by 2035 - BusinessWorld Online
Colgate PH marks 100 years with expanded oral health push - InsiderPH
Colgate-Palmolive Company $CL Shares Sold by Wilmington Savings Fund Society FSB - MarketBeat
The 2 Best Dividend Stocks to Buy Now and Hold Forever - AOL.com
Zacks.com featured highlights include Ross Stores, Globe Life, Broadcom, Colgate-Palmolive and TE Connectivity - The Globe and Mail
Zacks.com spotlighted companies such as Ross Stores, Globe Life, Broadcom, Colgate-Palmolive, and TE Connectivity. - Bitget
The 2 best dividend stocks to buy now and hold forever - MSN
Colgate-Palmolive: 2026 Guidance Is Conservative, But That Doesn't Make It A Buy (NYSE:CL) - Seeking Alpha
Danica Pension Livsforsikringsaktieselskab Acquires Shares of 498,132 Colgate-Palmolive Company $CL - MarketBeat
The 2 Best Dividend Stocks to Buy Now and Hold Forever - The Motley Fool
Colgate-Palmolive Co Stock (ISIN: US1845021021) Holds Steady Amid Consumer Staples Resilience in Vol - AD HOC NEWS
Colgate-Palmolive (CL) Announces Strategic Realignment of Operat - GuruFocus
Colgate-Palmolive updates segment reporting structure for Europe, Middle East and Africa - Investing.com Australia
Colgate-Palmolive updates segment reporting structure for Europe, Middle East and Africa By Investing.com - Investing.com South Africa
Colgate Palmolive said Russia and Belarus to be reported in Asia Pacific operating segmentSEC filing - marketscreener.com
Colgate-Palmolive (NYSE: CL) realigns segments and recasts 2023–2025 data - Stock Titan
14,647 Shares in Colgate-Palmolive Company $CL Purchased by Delta Global Management LP - MarketBeat
Clark Capital Management Group Inc. Sells 40,026 Shares of Colgate-Palmolive Company $CL - MarketBeat
Alliancebernstein L.P. Raises Stock Position in Colgate-Palmolive Company $CL - MarketBeat
Colgate-Palmolive raises dividend, adds Bristol Myers CEO to board - Investing.com Nigeria
The Zacks Analyst Blog Highlights Atmos Energy, Colgate-Palmolive and West Pharmaceutical Services - The Globe and Mail
Destination Wealth Management Grows Holdings in Colgate-Palmolive Company $CL - MarketBeat
Distillate Capital Partners LLC Buys New Holdings in Colgate-Palmolive Company $CL - MarketBeat
Chevy Chase Trust Holdings LLC Lowers Stock Holdings in Colgate-Palmolive Company $CL - MarketBeat
Colgate-Palmolive Co Stock (ISIN: US1941621039) Holds Steady Amid Defensive Oral Care Demand - AD HOC NEWS
Aquatic Capital Management LLC Makes New Investment in Colgate-Palmolive Company $CL - MarketBeat
Colgate-Palmolive Company $CL Holdings Boosted by Ameriprise Financial Inc. - MarketBeat
Hardik Jhaveri joins Colgate-Palmolive as Senior Marketing Director for South ASEAN Hub - bestmediainfo.com
Colgate-Palmolive Co Stock (ISIN: US1845021021) Holds Steady Amid Consumer Staples Resilience - AD HOC NEWS
Colgate-Palmolive Company $CL Stock Holdings Lowered by Capitolis Liquid Global Markets LLC - MarketBeat
Ossiam Lowers Stock Holdings in Colgate-Palmolive Company $CL - MarketBeat
Colgate-Palmolive (NYSE:CL) Gains Market Focus In S&P 500 Index Staples - Kalkine Media
Colgate-Palmolive raises dividend, adds Bristol Myers CEO to board By Investing.com - Investing.com Australia
Te Ahumairangi Investment Management Ltd Has $5.55 Million Stock Holdings in Colgate-Palmolive Company $CL - MarketBeat
Colgate-Palmolive Company (NYSE:CL) Plans Quarterly Dividend of $0.53 - MarketBeat
Colgate-Palmolive (CL) Increases Dividend Amidst Active Payout W - GuruFocus
Olympic ice dance stars Chock and Bates ring the NYSE bell after Milan medals - Stock Titan
Colgate-Palmolive Company $CL Shares Sold by Martingale Asset Management L P - MarketBeat
Arrowstreet Capital Limited Partnership Has $428.40 Million Stake in Colgate-Palmolive Company $CL - MarketBeat
Colgate-Palmolive Company (NYSE:CL) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Colgate-Palmolive Elects Christopher Boerner, Ph.D. to Board of Directors - citybiz
Finanzdaten der Colgate Palmolive Co-Aktie (CL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.17%
0.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):